Related references
Note: Only part of the references are listed.Multi-arm Phase IB study of TH-302 in combination with gemcitabine, docetaxel or pemetrexed
M. Borad et al.
EJC SUPPLEMENTS (2009)
Efficacy of Sequential High-Dose Doxorubicin and Ifosfamide Compared With Standard-Dose Doxorubicin in Patients With Advanced Soft Tissue Sarcoma: An Open-Label Randomized Phase II Study of the Spanish Group for Research on Sarcomas
Joan Maurel et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
CA 19-9 and Lewis Antigens in Pancreatic Cancer Reply
Adam C. Berger et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Molecular imaging of hypoxia
Kenneth A. Krohn et al.
JOURNAL OF NUCLEAR MEDICINE (2008)
Phase III trial of two Investigational schedules of ifosfamide compared with standard-dose doxorubicin in advanced or metastatic soft tissue sarcoma: A European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group study
Paul Lorigan et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Phase III trial of paclitaxel plus carboplatin with or without tirapazamine in advanced non-small-cell lung cancer: Southwest Oncology Group Trial S0003
SK Williamson et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
The distribution of the anticancer drug doxorubicin in relation to blood vessels in solid tumors
AJ Primeau et al.
CLINICAL CANCER RESEARCH (2005)
The biology of hypoxia: the role of oxygen sensing in development, normal function, and disease
AJ Giaccia et al.
GENES & DEVELOPMENT (2004)
[18F]FMISO and [18F]FDG PET imaging in soft tissue sarcomas:: correlation of hypoxia, metabolism and VEGF expression
JG Rajendran et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2003)
Hypoxia in human soft tissue sarcomas:: Adverse impact on survival and no association with p53 mutations
M Nordsmark et al.
BRITISH JOURNAL OF CANCER (2001)
New guidelines to evaluate the response to treatment in solid tumors
F Duffaud et al.
BULLETIN DU CANCER (2000)
New guidelines to evaluate the response to treatment in solid Tumors
P Therasse et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Share Paper
